Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effects of COX-inhibiting drugs on skeletal muscle adaptations to resistance exercise
2014-004872-47Phase 2Completed
- Sponsor
- Karolinska Institutet
- Start
- May 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of ibuprofen 600 mg ER and aspirin (2 arms), sponsored by Karolinska Institutet. Primary endpoint: Muscle volume. Started May 2015; status: completed.
02
Drugs
ibuprofen 600 mg ERaspirin
Beyond the preview
Go deeper on 2014-004872-47.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-004872-47.